Media Center
Welcome to EpiCept’s Media Center. The Media Center gives you immediate access to timely and relevant information about our company. In this section you will find information and resources including current and archived EpiCept press releases, upcoming events, publications and our annual reports.
News
May 9th, 2012 - EpiCept Reports First Quarter 2012 Operating and Financial Results
May 3rd, 2012 - EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012
April 10th, 2012 - EpiCept's AmiKet™ Receives Fast Track Designation from FDA
April 4th, 2012 - EpiCept's Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis
March 29th, 2012 - EpiCept to Raise $1.1 Million in Registered Direct Offering
Publications
Oncology
Hellstrand K, Hermodsson S.
Histamine H2-receptor-mediated regulation of human natural killer cell activity.
>> More
Pain Management
Sawynok J, Esser MJ, Reid AR
Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82 (1999) 149-158.
>> More
Events
May 9th, 2012 - EpiCept Corporation First Quarter-2012 Earnings Call
February 29th, 2012 - EpiCept Corporation Fourth Quarter-Year End 2011 Earnings Call
February 13th, 2012 - BIO CEO & Investor Conference
January 10th, 2012 - 2012 OneMedForum
January 9th, 2012 - Biotech Showcase 2012